U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07629128) titled 'Patients With Primary Biliary Cholangitis(PBC)' on May 18.
Brief Summary: Primary Biliary Cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by the progressive destruction of small intrahepatic bile ducts, leading to chronic cholestasis, hepatic fibrosis, and, in advanced stages, cirrhosis. Recent advances in the understanding of PBC pathophysiology have highlighted the central role of immune, inflammatory, and metabolic alterations in disease onset and progression.
Study Start Date: May 18
Study Type: OBSERVATIONAL
Condition:
Primary Biliary Cholangitis
Liver Fibrosis
Cirrhosis, Liver
Blood Sugar; ...